地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：17754422825
传真：18771997407
邮箱：sales@amyjet.com
Altogen Biosystems公司成立于1978年，是体外诊断工业和全球实验室原材料的主要供应商。我们为我们行业中最大的跨国公司提供广泛的人类纯化蛋白；单克隆和多克隆抗体；真菌、寄生、细菌和病毒抗原；以及用于体外诊断的疾病状态血浆。
Altogen Biosystems is a biotechnology company that develops and manufactures transfection kits for life sciences research, drug discovery and development. Altogen® In Vivo transfection reagents provide effective delivery of biomolecules into target tissues. Cell transfection kits are optimized for specific cancer cell lines and primary cell cultures. Efficient delivery of cargo molecules (DNA, RNA, proteins) enabled by advanced reagent formulation and optimized transfection protocols. Altogen Biosystems develops new in vitro and in vivo delivery technologies by applying polymer chemistry, molecular and cell biology expertise.
Altogen Biosystems公司的主要产品包括：
Fungal, protozoan, bacterial and viral antigens
Monoclonal antibodies
Polyclonal antibodies
Disease state human plasma
Purified native and recombinant human proteins
" data-original="http://aves.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Altogen Biosystems"> Altogen Biosystems
invivoCrown IV0108替换BioXCell BE0034
invivoCrown IV0120替换BioXCell BE0015-1
invivoCrown IV0106替换BioXCell BE0090
<艾美捷科技代理Synthelis Biotech品牌全系列产品
Synthelis Biotech是一家法国公司，专注于蛋白质的生产、纯化与表征，公司致力于助力疫苗、生物制剂、酶、工程蛋白、诊断工具以及高通量分子或配体筛选技术的开发。Synthelis Biotech提供经过验证的蛋白质，其活性和纯度均根据特定应用（候选药物筛选、抗体与疫苗开发、结构生物学、体外诊断、蛋白质载体化）量身定制。Synthelis Biotech专利的无细胞技术使客户能够从不同蛋白家族（GPCRs、离子通道、转运蛋白等）和不同形式（蛋白脂质体、纳米盘、去垢剂溶解形式或可溶形式）中选择合适的蛋白质。凭借其专利技术，Synthelis 能够在数小时内合成各类蛋白质：包括膜蛋白、毒性蛋白、修饰蛋白等，应用于药物筛选、疫苗与抗体开发、结构生物学以及体外诊断等领域。同时可按需进行修饰（荧光或同位素标记、非天然氨基酸掺入、截短或突变形式等）。
▍Synthelis Biotech产品列表
| 分类 | 品名 | Protein | Origin | Format | Reference | Quantity | 分子量 |
| Viral Proteins | E1 | Envelop protein 1 | Hepatitis C virus | Proteoliposome | PL011 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 21 kDa |
| Viral Proteins | E2 | Envelop protein 1 | Hepatitis C virus | Proteoliposome | PL010 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 21 kDa |
| Viral Proteins | N-protein | Nucleocapsid Protein (COVID-19) | SARS-Cov 2 virus | Soluble | S-144 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 47,7 kDa |
| Viral Proteins | F5L | Vaccinia virus major membrane protein | Vaccinia virus | Proteoliposome | PL007 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 39.0 kDa |
| Viral Proteins | HCV p7 | Hepatitis C virus P7 | HCV virus | Proteoliposome | PL042 | 10µg, 20µg, 50µg, 100µg, 200µg, 500µg | 7 kDa |
| GPCRs | APJ/AR | Apelin Receptor | Human | Proteoliposome | PL061 | 10 µg, 50 µg ,100 µg | 44.7 kDa |
| GPCRs | B2R | Bradykinin receptor 2 | Human | Proteoliposome | PL080 | 10 µg, 50 µg ,100 µg | 47.0 kDa |
| GPCRs | BR | Bacteriorhodopsin | Bacteria | Proteoliposome | PL027 | 10 µg, 50 µg ,100 µg | 29.4 kDa |
| GPCRs | CCR1 | C-C chemokine receptor type 1 | Human | Proteoliposome | PL021 | 10 µg, 50 µg ,100 µg | 43.7 kDa |
| GPCRs | CCR2a | C-C chemokine receptor type 2, isoform a | Human | Proteoliposome | PL022 | 10 µg, 50 µg, 100 µg | 44.5 kDa |
| GPCRs | CCR2b | C-C chemokine receptor type 2, isoform b | Human | Proteoliposome | PL023 | 10µg, 20µg,100 µg, 200 µg | 42 kDa |
| GPCRs | CCR5 | C-C chemokine receptor type 5 | Human | Proteoliposome | PL024 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 40 kDa |
| GPCRs | CXCR4 | C-X-C chemokine receptor type 4 | Human | Proteoliposome | PL016 | 10 µg, 50 µg, 100 µg | 43 kDa |
| GPCRs | CXCR4-Detergent | C-X-C chemokine receptor type 4 | Human | Detergent | D016 | 25µg ,100 µg ,500 µg,bulk | 40 kDa |
| GPCRs | GLP1R | Glucagon-like peptide 1 receptor | Human | Proteoliposome | PL067 | 10 µg, 50 µg, 100 µg | 55.5 kDa |
| GPCRs | GPR50 | G-protein coupled receptor 50 | Human | Proteoliposome | PL095 | 10 µg, 50 µg, 100 µg | 67.4 kDa |
| GPCRs | GPR54 | G-protein coupled receptor 54 | Human | Proteoliposome | PL097 | 10 µg, 50 µg ,100 µg | 45.2 kDa |
| GPCRs | HMOP | Mu-type opioid receptor | Human | Proteoliposome | PL025 | - | - |
| GPCRs | MT1 | Melatonin receptor | Human | Proteoliposome | PL028 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 40 kDa |
| GPCRs | RXFP1 | Relaxin receptor 1 | Human | Proteoliposome | PL068 | 10 µg, 50 µg ,100 µg | 89.1 kDa |
| Ion Channels | kir1.1b | ATP-sensitive inward rectifier potassium channel 1 isoform b | Mouse | Proteoliposome | PL031 | 10µg, 20µg,100 µg, 200 µg, 500 µg, bulk | 42.7 kDa |
| Ion Channels | kv1.2 | Potassium voltage-gated channel subfamily A, member 2 | Rat | Proteoliposome | PL037 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 57 kDa |
| Ion Channels | kv1.3 | Potassium voltage-gated channel subfamily A, member 3 | Mouse | Proteoliposome | PL036 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 58 kDa |
| Ion Channels | VDAC1 | Voltage-Dependent Anion Channel 1 | Human | Proteoliposome | PL029 | 10 µg, 50 µg ,100 µg | 30.7kDa |
| Ion Channels | VDAC1 – Detergent | Voltage-Dependent Anion Channel 1 | Human | Detergent | D029 | 10 µg, 50 µg, 100 µg | 30.7kDa |
| Ligands | SDF1a | Stromal cell-derived factor 1 | Human | Soluble | S069 | 10 µg, 50 µg ,100 µg | 10.7 kDa |
| Porins | OEP24 | Outer envelope pore protein 24, chloroplastic | Plant | Proteoliposome | PL040 | 10 µg, 50 µg ,100 µg | 24 kDa |
| Porins | OprF | Outer membrane porin F | Bacteria | Proteoliposome | PL045 | 10 µg, 50 µg, 100 µg | 40 kDa |
| Enzymes | gp91phox (Nox2 subunit) | gp91phox | Human | Proteoliposome | PL008 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 55 kDa |
| Enzymes | KMO | Kynurenine 3-monooxygenase | Human | Proteoliposome | PL005 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 55,8 kDa |
| Enzymes | Nox2, p22 Phox | Cytochrome b-245 light chain | Human | Proteoliposome | PL039 | 10 µg, 50 µg ,100 µg | 23,5 kDa |
| Enzymes | Nox4 | Nox4 | Human | Proteoliposome | PL059 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 67 kDa |
| Enzymes | PORCN | Protein-Cysteine N-palmitoyltransferase porcupine | Human | Proteoliposome | PL006 | 10 µg, 50 µg, 100 µg | 55.5 kDa |
| Enzymes | TF | Tissue factor | Human | Proteoliposome | PL053 | 10µg, 20µg ,50µg, 100 µg , 200µg, 500 µg,bulk | 33 kDa |
| Enzymes | T7 RNA Pol | T7 RNA Polymerase | Bacteriophage T7 | Soluble | S192 | 10 µg, 50 µg, 100µg | 100.1 kDa |
| Enzymes | DsbC | Disulfide bond isomerase | E.coli | Soluble | S197 | customized quantity on request. | 25.4 kDa |
| Receptors | CLDN 18.2 | Claudin 18.2 Protein | Human | Proteoliposome | PL119 | 10 µg, 50 µg, 100 µg | 30 kDa |
| Transcriptional regulators | AROS | Active regulator of SIRT1 | Human | Proteoliposome | S052 | 10µg, 20µg ,100 µg , 200 µg, 500 µg,bulk | 15,4 kDa |
| Transporters | Bak | Bcl-2 homologous antagonist killer | Human | Proteoliposome | PL038 | 25µg ,100 µg ,500 µg,bulk | 17 kDa |
| Transporters | EspH | Cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli | Bacteria | Proteoliposome | PL051 | 10 µg, 50 µg, 100 µg | 21.9 kDa |
| Transporters | HCV p7 | Hepatitis C virus P7 | Virus | Proteoliposome | PL042 | 25µg ,100 µg ,500 µg,bulk | 7 kDa |
| Transporters | NhaA | Na(+)/H(+) antiporter NhaA | E. coli | Proteoliposome | PL032 | 10 µg, 50 µg, 100 µg | 43.9 kDa |
| Transporters | UCP1 | Mitochondrial brown fat uncoupling protein 1 | Mitochondria | Proteoliposome | PL047 | 10 µg, 50 µg, 100 µg | 35.1 kDa |
invivoCrown IV0109替换BioXCell BE0164
invivoCrown IV0115替换BioXCell BE0060
invivoCrown IV0105替换BioXCell BE0089
艾美捷科技代理ATTO Biotech全系列产品。
ATTO Biotech专注于开发和提供生命科学研发用的创新产品及服务。公司位于中国上海，主要为全球生物医药类企业及研发机构提供高度专业化的细胞培养材料和技术服务。爱拓生物科技推出的含组织特异性基质成分细胞培养添加剂，突破了传统细胞培养技术的瓶颈，为全球医药和医学生物学研究者提供了简单、精确和高效的解决方案，是划时代技术革命性产品。
ATTO BIOTECH is a German company based inShanghaiChina. We are no giant on an international scale but a global leader in producing cell culture supplements containing tissue-specific decellularized extracellular matrix (ECM) components. Customers choose ATTO BIOTECH for its true research tools of tomorrow to create clinically relevant in vitro solutions that fundamentally change the way we understand human diseases. Our range of highly innovative products has wide applications in life sciences industries and academic institutions.
主要产品包括：
心脏组织特异性细胞外基质添加剂
(Cat# ECM201) heart-specific ECM supplements (hECMs), 10×
动/静脉血管组织特异性细胞外基质添加剂
(Cat# ECM202) artery/vein-specific ECM supplements (aECMs/vECMs), 10×
脑组织特异性细胞外基质添加剂
(Cat# ECM203) brain-specific ECM supplements (bECMs), 10×
胃肠组织特异性细胞外基质添加剂
(Cat# ECM204) gastrointestine-specific ECM supplements (gECMs), 10×
食管组织特异性细胞外基质添加剂
(Cat# ECM205) esophagus-specific ECM supplements (eECMs), 10×
肾胀组织特异性细胞外基质添加剂
(Cat# ECM206) kidney-specific ECM supplements (kECMs), 10×
肝组织特异性细胞外基质添加剂
(Cat# ECM207) liver-specific ECM supplements (liECMs), 10×
脾组织特异性细胞外基质添加剂
(Cat# ECM208) spleen-specific ECM supplements (sECMs), 10×
肺组织特异性细胞外基质添加剂
(Cat# ECM209) lung-specific ECM supplements (luECMs), 10×
气管组织特异性细胞外基质添加剂
(Cat# ECM210) trachea-specific ECM supplements (tECMs), 10×
" data-original="http://aves.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ATTO Biotech"> ATTO Biotech
invivoCrown IV0119替换BioXCell BE0004-1
地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18995651644
传真：18995651644
邮箱：sales@amyjet.com
0.1363
